Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Ma, Wei hong ^a   Wang, Xiu ling ^b   Du, Yi meng ^a   Wang, Yi biao ^a   Zhang, Yan ^a   Wei, De e ^c   Guo, Lin lin ^a   Bu, Pei Li ^b  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLYCOPROTEIN GP 39; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN YKL 40; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; FEMORAL ARTERY; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE PRESSURE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOKINES; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CAROTID ARTERIES; CASE-CONTROL STUDIES; CREATININE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMORAL ARTERY; HUMANS; HYPERTENSION; LECTINS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PULSE WAVE ANALYSIS; RISK ASSESSMENT; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; UP-REGULATION; VASCULAR STIFFNESS;

EID: 84861464881     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-35     Document Type: Article

References (15)

1. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187. 10.1097/HJH.0b013e3281fc975a, 17563527.
2. Tomiyama H, Nishikawa E, Abe M, Nakagawa K, Fujiwara M, Yamamoto A, Yoshida H, Doba N. Carotid arterial distensibility is an important determinant of improvement in autonomic balance after successful coronary angioplasty. J Hypertens 2000, 18:1621-1628. 10.1097/00004872-200018110-00013, 11081775.
3. Watanabe S, Okura T, Kitami Y, Hiwada K. Carotid hemodynamic alterations in hypertensive patients with insulin resistance. Am J Hypertens 2002, 15:851-856. 10.1016/S0895-7061(02)02988-6, 12372671.
4. Kuo HK, Al Snih S, Kuo YF, Raji MA. Cross-sectional associations of albuminuria and C-reactive protein with functional disability in older adults with diabetes. Diabetes Care 2011, 34:710-717. 10.2337/dc10-1977, 3041212, 21300788.
5. Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 2006, 55:221-227. 10.1007/s00011-006-0076-y, 16955240.
6. Rathcke CN, Vestergaard H. YKL-40-an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 2009, 23:8-61.
7. Martins D, Pimenta G, Constantino L, Santos T, Rosendo I, Matias C, Miranda P, Francisco MP, Neto MG, Santiago LM. Ankle-brachial index according to pulse pressure and microalbuminuria in hypertensive patients: a prospective study in family medicine. Rev Port Cardiol 2010, 29:751-764.
8. Kawamoto R, Kohara K, Tabara Y, Miki T, Ohtsuka N, Kusunoki T, Yorimitsu N. An association between decreased estimated glomerular filtration rate and arterial stiffness. Inter Med 2008, 47:593-598.
9. Berni A, Giuliani A, Tartaglia F, Tromba L, Sgueglia M, Blasi S, Russo G. Effect of vascular risk factors on increase in carotid and femoral intima-media thickness. Identification of a risk scale. Atherosclerosis 2011, 216:109-114. 10.1016/j.atherosclerosis.2011.01.034, 21349522.
10. Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 2009, 32:323-328. 2628702, 18957531.
11. Masajtis-Zagajewska A, Majer J, Nowicki M. Effect of moxonidine and amlodipine on serum YKL-40, plasma lipids and insulin sensitivity in insulin-resistant hypertensive patients-a randomized, crossover trial. Hypertens Res 2010, 33:348-353. 10.1038/hr.2010.6, 20139920.
12. Yildiz M. Arterial distensibility in chronic inflammatory rheumatic disorders. Open Cardiovasc Med 2010, 23:83-88.
13. Krantz MJ, Long CS, Hosokawa P, Karimkahani E, Dickinson M, Estacio RO, Masoudi FA, Havranek EP. Pulse wave velocity and carotid atherosclerosis in White and Latino patients with hypertension. BMC Cardiovasc Disord 2011, 11:15. 10.1186/1471-2261-11-15, 3080337, 21481252.
14. Shao R, Hamel K, Petersen L, Cao QJ, Arenas RB, Bigelow C, Bentley B, Yan W. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene 2009, 28:4456-4468. 10.1038/onc.2009.292, 2795793, 19767768.
15. Horbinski C, Wang G, Wiley CA. YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas. Int J Clin Exp Pathol 2010, 3:226-237. 2836500, 20224722.